Does mucosal remodeling in chronic rhinosinusitis result in irreversible mucosal disease?

Laryngoscope

Volumn 122, Issue 1, 2012, Pages 225-229

  Bassiouni, Ahmed ^a   Naidoo, Yuresh ^a   Wormald, Peter John ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Chronic rhinosinusitis; irreversible disease; irreversible mucosal changes; mucosal remodeling; radical sinus surgery; recalcitrant chronic rhinosinusitis; refractory chronic rhinosinusitis; upper airway remodeling

Indexed keywords

COLLAGEN;

AIRWAY REMODELING; ENDOSCOPIC SINUS SURGERY; FIBROSIS; INFLAMMATION; MUCOSAL DISEASE; MUCOSAL REMODELING; NOSE POLYP; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RHINOSINUSITIS;

AIRWAY REMODELING; CHRONIC DISEASE; COLLAGEN; FIBROSIS; HUMANS; PROGNOSIS; RESPIRATORY MUCOSA; RHINITIS; SINUSITIS;

EID: 84255214170     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.22374     Document Type: Review

References (58)

1. Bousquet J, Chanez P, Lacoste JY, et al. Asthma: a disease remodeling the airways. Allergy 1992; 47: 3-11.
2. Carter PM, Heinly TL, Yates SW, Lieberman PL,. Asthma: the irreversible airways disease. J Investig Allergol Clin Immunol 1997; 7: 566-571. (Pubitemid 28045193)
3. Pascual RM, Peters SP,. Airway remodeling contributes to the progressive loss of lung function in asthma: an overview. J Allergy Clin Immunol 2005; 116: 477-486; quiz 487. (Pubitemid 41267113)
4. Ponikau JU, Sherris DA, Kephart GM, et al. Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: is the histopathology similar to asthma? J Allergy Clin Immunol 2003; 112: 877-882. (Pubitemid 37412054)
5. Pawankar R, Nonaka M,. Inflammatory mechanisms and remodeling in chronic rhinosinusitis and nasal polyps. Curr Allergy Asthma Rep 2007; 7: 202-208. (Pubitemid 46784199)
6. Lazarus S,. Mild persistent asthma: Is any treatment needed? J Allergy Clin Immunol 2006; 118: 805-808. (Pubitemid 44498775)
7. Serpero L, Petecchia L, Sabatini F, et al. The effect of transforming growth factor (TGF)-beta1 and (TGF)-beta2 on nasal polyp fibroblast activities involved upper airway remodeling: modulation by fluticasone propionate. Immunol Lett 2006; 105: 61-67. (Pubitemid 43674135)
8. Little SC, Early SB, Woodard CR, et al. Dual action of TGF-β1 on nasal-polyp derived fibroblasts. Laryngoscope 2008; 118: 320-324. (Pubitemid 351640210)
9. Molet SM, Hamid QA, Hamilos DL,. IL-11 and IL-17 expression in nasal polyps: relationship to collagen deposition and suppression by intranasal fluticasone propionate. Laryngoscope 2003; 113: 1803-1812. (Pubitemid 37210986)
10. Wang QP, Escudier E, Roudot-Thoraval F, Abd-Al Samad I, Peynegre R, Coste A,. Myofibroblast accumulation induced by transforming growth factor-beta is involved in the pathogenesis of nasal polyps. Laryngoscope 1997; 107: 926-931. (Pubitemid 27284320)
11. Sobol SE, Fukakusa M, Christodoulopoulos P, et al. Inflammation and remodeling of the sinus mucosa in children and adults with chronic sinusitis. Laryngoscope 2003; 113: 410-414. (Pubitemid 36292862)
12. Van Bruaene N, Derycke L, Perez-Novo CA, et al. TGF-beta signaling and collagen deposition in chronic rhinosinusitis. J Allergy Clin Immunol 2009; 124: 253-259, 259.e1-2.
13. Silvestri M, Sabatini F, Scarso L, Cordone A, Dasic G, Rossi GA,. Fluticasone propionate downregulates nasal fibroblast functions involved in airway inflammation and remodeling. Int Arch Allergy Immunol 2002; 128: 51-58. (Pubitemid 34621666)
14. Yu R-li, Zhu D-dong, Dong Z,. Effects of glucocorticoid on tissue remodeling of nasal mucosa of chronic rhinosinusitis with nasal polypsis after endoscopic surgery [in Chinese]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2006; 41: 773-776.
15. Burgel P-R, Cardell LO, Ueki IF, Nadel JA,. Intranasal steroids decrease eosinophils but not mucin expression in nasal polyps. Eur Respir J 2004; 24: 594-600. (Pubitemid 39406133)
16. Mullol J, Lopez E, Roca-Ferrer J, et al. Effects of topical anti-inflammatory drugs on eosinophil survival primed by epithelial cells. Additive effect of glucocorticoids and nedocromil sodium. Clin Exp Allergy 1997; 27: 1432-1441. (Pubitemid 28005242)
17. Fokkens W, Lund V, Mullol J,. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 2007;(20): 1-136.
18. Li X, Meng J, Qiao X, et al. Expression of TGF, matrix metalloproteinases, and tissue inhibitors in Chinese chronic rhinosinusitis. J Allergy Clin Immunol 2010; 125: 1061-1068.
19. Eisma RJ, Allen JS, Lafreniere D, Leonard G, Kreutzer DL,. Eosinophil expression of transforming growth factor-beta and its receptors in nasal polyposis: role of the cytokines in this disease process. Am J Otolaryngol 1997; 18: 405-411. (Pubitemid 27495806)
20. Elovic A, Wong DT, Weller PF, Matossian K, Galli SJ,. Expression of transforming growth factors-alpha and beta 1 messenger RNA and product by eosinophils in nasal polyps. J Allergy Clin Immunol 1994; 93: 864-869. (Pubitemid 24154104)
21. Ohno I, Lea RG, Flanders KC, et al. Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). J Clin Invest 1992; 89: 1662-1668.
22. Coste A, Lefaucheur JP, Wang QP, et al. Expression of the transforming growth factor beta isoforms in inflammatory cells of nasal polyps. Arch Otolaryngol Head Neck Surg 1998; 124: 1361-1366. (Pubitemid 28564112)
23. Watelet J-B, Claeys C, Perez-Novo C, Gevaert P, Van Cauwenberge P, Bachert C,. Transforming growth factor beta1 in nasal remodeling: differences between chronic rhinosinusitis and nasal polyposis. Am J Rhinol 2004; 18: 267-272. (Pubitemid 39618654)
24. Saitoh T, Kusunoki T, Yao T, et al. Relationship between epithelial damage or basement membrane thickness and eosinophilic infiltration in nasal polyps with chronic rhinosinusitis. Rhinology 2009; 47: 275-279.
25. Saitoh T, Kusunoki T, Yao T, et al. Role of interleukin-17A in the eosinophil accumulation and mucosal remodeling in chronic rhinosinusitis with nasal polyps associated with asthma. Int Arch Allergy Immunol 2010; 151: 8-16.
26. Bachert C, Gevaert P, Holtappels G, Johansson SG, van Cauwenberge P,. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001; 107: 607-614. (Pubitemid 32397745)
27. Haruna S, Nakanishi M, Otori N, Moriyama H,. Histopathological features of nasal polyps with asthma association: an immunohistochemical study. Am J Rhinol 2004; 18: 165-172. (Pubitemid 39029214)
28. Dhong H-J, Kim HY, Cho D-Y,. Histopathologic characteristics of chronic sinusitis with bronchial asthma. Acta Otolaryngol 2005; 125: 169-176. (Pubitemid 40293208)
29. Jankowski R, Bouchoua F, Coffinet L, Vignaud JM,. Clinical factors influencing the eosinophil infiltration of nasal polyps. Rhinology 2002; 40: 173-178. (Pubitemid 36040518)
30. Ardehali MM, Amali A, Bakhshaee M, Madani Z, Amiri M,. The comparison of histopathological characteristics of polyps in asthmatic and nonasthmatic patients. Otolaryngol Head Neck Surg 2009; 140: 748-751.
31. Rehl RM, Balla AA, Cabay RJ, Hearp ML, Pytynia KB, Joe SA,. Mucosal remodeling in chronic rhinosinusitis. Am J Rhinol 2007; 21: 651-657.
32. Nonaka M, Pawankar R, Saji F, Yagi T,. Eotaxin synthesis by nasal polyp fibroblasts. Acta Otolaryngol 1999; 119: 816-820. (Pubitemid 30070303)
33. Yoshifuku K, Matsune S, Ohori J, Sagara Y, Fukuiwa T, Kurono Y,. IL-4 and TNF-alpha increased the secretion of eotaxin from cultured fibroblasts of nasal polyps with eosinophil infiltration. Rhinology 2007; 45: 235-241.
34. Saji F, Nonaka M, Pawankar R,. Expression of RANTES by IL-1 beta and TNF-alpha stimulated nasal polyp fibroblasts. Auris Nasus Larynx 2000; 27: 247-252. (Pubitemid 30251878)
35. Smith TL, Mendolia-Loffredo S, Loehrl TA, Sparapani R, Laud PW, Nattinger AB,. Predictive factors and outcomes in endoscopic sinus surgery for chronic rhinosinusitis. Laryngoscope 2005; 115: 2199-2205. (Pubitemid 44391635)
36. Kim HY, Dhong H-J, Chung SK, Chung Y-J, Kim M-G,. Clinical characteristics of chronic rhinosinusitis with asthma. Auris Nasus Larynx 2006; 33: 403-408. (Pubitemid 44486610)
37. Kountakis SE, Bradley DT,. Effect of asthma on sinus computed tomography grade and symptom scores in patients undergoing revision functional endoscopic sinus surgery. Am J Rhinol 2003; 17: 215-219. (Pubitemid 37098501)
38. Kim J-E, Kountakis SE,. The prevalence of Samter's triad in patients undergoing functional endoscopic sinus surgery. Ear Nose Throat J 2007; 86: 396-399. (Pubitemid 351954491)
39. Schaitkin B, May M, Shapiro A, Fucci M, Mester SJ,. Endoscopic sinus surgery: 4-year follow-up on the first 100 patients. Laryngoscope 1993; 103: 1117-1120. (Pubitemid 23297097)
40. Amar YG, Frenkiel S, Sobol SE,. Outcome analysis of endoscopic sinus surgery for chronic sinusitis in patients having Samter's triad. J Otolaryngol 2000; 29: 7-12. (Pubitemid 30120552)
41. Awad OG, Lee JH, Fasano MB, Graham SM,. Sinonasal outcomes after endoscopic sinus surgery in asthmatic patients with nasal polyps: a difference between aspirin-tolerant and aspirin-induced asthma? Laryngoscope 2008; 118: 1282-1286.
42. Batra PS, Kern RC, Tripathi A, et al. Outcome analysis of endoscopic sinus surgery in patients with nasal polyps and asthma. Laryngoscope 2003; 113: 1703-1706. (Pubitemid 37210970)
43. Liang L, Liu H-gang, He C-yan,. Morphological study of thick basement membrane-like layer in chronic rhinosinusitis [in Chinese]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2006; 41: 31-34.
44. Chan KH, Abzug MJ, Coffinet L, Simoes EA, Cool C, Liu AH,. Chronic rhinosinusitis in young children differs from adults: a histopathology study. J Pediatr 2004; 144: 206-212. (Pubitemid 38869396)
45. Pedersen S,. Why does airway inflammation persist? Is it failure to treat early? Am J Respir Crit Care Med 2000; 161 (3 pt 2): S182-S185. (Pubitemid 30177042)
46. Stammberger H,. Endoscopic endonasal surgery-concepts in treatment of recurring rhinosinusitis. Part I. Anatomic and pathophysiologic considerations. Otolaryngol Head Neck Surg 1986; 94: 143-147. (Pubitemid 16103210)
47. Kennedy DW, Zinreich SJ, Rosenbaum AE, Johns ME,. Functional endoscopic sinus surgery. Theory and diagnostic evaluation. Arch Otolaryngol 1985; 111: 576-582. (Pubitemid 16218764)
48. Thiele A, Holzhausen H-J, Riederer A, Knipping S,. Mucosal remodeling in chronic rhinosinusitis without nasal polyposis-an ultrastructural evaluation [in German]. Laryngorhinootologie 2010; 89: 352-357.
49. Toskala E, Rautiainen M,. Electron microscopy assessment of the recovery of sinus mucosa after sinus surgery. Acta Otolaryngol 2003; 123: 954-959. (Pubitemid 37346555)
50. Fang SY,. Normalization of maxillary sinus mucosa after FESS. A prospective study of chronic sinusitis with nasal polyps. Rhinology 1994; 32: 137-140.
51. Richtsmeier WJ,. Top 10 reasons for endoscopic maxillary sinus surgery failure. Laryngoscope 2001; 111 (11 pt 1): 1952-1956. (Pubitemid 33042110)
52. Cutler JL, Duncavage JA, Matheny K, Cross JL, Miman MC, Oh CK,. Results of Caldwell-Luc after failed endoscopic middle meatus antrostomy in patients with chronic sinusitis. Laryngoscope 2003; 113: 2148-2150. (Pubitemid 38063837)
53. Kikawada T, Nonoda T, Matsumoto M, Kikura M, Kikawada K,. Treatment of intractable diseased tissue in the maxillary sinus after endoscopic sinus surgery with high-pressure water jet and preservation of the periosteum. Arch Otolaryngol Head Neck Surg 2000; 126: 55-61. (Pubitemid 30051493)
54. Abd el-Fattah H, Nour YA, el-Daly A,. Endoscopic radical antrectomy: a permanent replacement for the Caldwell-Luc operation. J Laryngol Otol 2008; 122: 268-276. (Pubitemid 351364376)
55. Woodworth BA, Parker RO, Schlosser RJ,. Modified endoscopic medial maxillectomy for chronic maxillary sinusitis. Am J Rhinol 2006; 20: 317-319. (Pubitemid 44083414)
56. Rodriguez MJ, Sargi Z, Casiano RR,. Extended maxillary sinusotomy in isolated refractory maxillary sinus disease. Otolaryngol Head Neck Surg 2007; 137: 508-510. (Pubitemid 47320876)
57. Cho D-Y, Hwang PH,. Results of endoscopic maxillary mega-antrostomy in recalcitrant maxillary sinusitis. Am J Rhinol 2008; 22: 658-662.
58. Wormald PJ,. Salvage frontal sinus surgery: the endoscopic modified Lothrop procedure. Laryngoscope 2003; 113: 276-283. (Pubitemid 36176994)